Lupin Pharmaceuticals Inc is recalling 12,888 bottles of Famotidine for oral suspension USP, 40 mg/5 ml, 50 ml bottle, manufactured by Lupin Ltd at its Goa facility, it added. The ongoing nation wide voluntary recall is a class III recall, the report said.
Famotidine for oral suspension is indicated in short-term treatment of active duodenal ulcer, active benign gastric ulcer and gastroesophageal reflux disease. As per the USFDA, a class III recall is initiated in "a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences".
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)